Welcome to BioReagent Hub Hotline:19920083827
本站自营/精选产品 www.yeasen.com  |  价格与库存以本站实时信息为准
本站精选 · 品质自营查看原始页面 ›
Vendor Tel:400-6111-883
Product data sheet PD-94157ES
Biotinylated Human IL-1R3/IL-1 RAcP Protein, His-Avi Tag Biotinylated Human IL-1R3/IL-1 RAcP Protein, His-Avi Tag
Enquiry

Tell us your volume and application; we reply with a quote.

Start enquiry

Biotinylated Human IL-1R3/IL-1 RAcP Protein, His-Avi Tag

Scan for product
HEK293细胞表达系统免疫学研究
Product no.94157ES Sizes3 options SourceYeasen · Official
Cat. No. 94157ES60
现货 $6,885.00
Qty 1
Enquire now
Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status
94157ES60 100 μg $6,885.00 现货 Enquire
94157ES76 500 μg $24,115.00 现货 Enquire
94157ES25 25 μg $2,285.00 现货 Enquire
Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen
Cat.No94157ES
Specification高纯度、高活性、低内毒素、高批间一致性
Origin翌圣生物科技(上海)股份有限公司
技术平台 HEK293细胞表达系统
应用方法 免疫学研究研究IL-1家族信号通路
适用物种种属 人
检测方法 酶联免疫吸附测定法 SDS-聚丙烯酰胺凝胶电泳 高效液相色谱法 鲎试剂法
生物特性参数 蛋白类型生物素化重组蛋白 种属来源人 生物活性描述Immobilized Biotinylated Human IL-1R3 His Tag at 0.5μg/ml on the streptavidin precoated plate (5μg/ml). Dose response curve for Anti-IL-1R3 Antibody hFc Tag with the EC50 of 2.4ng/ml determined by ELISA. 应用研究IL-1家族信号通路
样本类型 重组蛋白
技术参数 纯度> 95% as determined by SDS-PAGE and HPLC. 内毒素水平< 1.0 EU per μg by the LAL method. 分子量Predicted MW 42 kDa; migrates to 52-70 kDa due to glycosylation. 制剂形式Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization. 活性ELISA EC50 of 2.4 ng/ml for Anti-IL-1R3 Antibody hFc Tag. 储存条件-25 ~ -15℃保存,收到货后有效期2年;复溶后,无菌条件下-85 ~ -65℃保存,3个月有效期。 表达序列Ser21-Glu359 表达系统HEK293 标签C-His-Avi 外观Lyophilized Powder 复溶方法开盖前先离心,使用蒸馏水复溶冻干蛋白,复溶浓度超过100 μg/mL,建议分装避免反复冻融。 Accession号Q9NPH3-1 产品别称IL1RAP IL-1RAP C3orf13 IL-1 R3 IL-1 RAcP

Recommended reading

Related products

✉Email 💬Message 👤Member
↑Top